Metabolism and biological activity of oligomeric procyanidins Not Applicable
Conditions
Interventions
Ten healthy volunteers will be enrolled and randomized by block randomization to consume two capsules per day (one in the morning and one in the evening) of Vitis vinifera extract (300 mg oligomeric p
Sponsors
University of Milan
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Women and men 2. Aged 18-40 years 3. BMI 18-25 kg/m² 4. Healthy 5. No smokers
Exclusion criteria
Exclusion criteria: 1. Smokers 2. Allergy to grape 3. Gastrointestinal disorder 4. Liver and renal disease 5. Antibiotic treatment 5. Use of supplements
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Urinary excretion of oligomeric proanthocyanidin-derived human phenyl-?-valerolactone metabolite from Vitis vinifera, measured using high-resolution mass spectrometry techniques at baseline and at 1, 2, 4, 6, 10, 12, 14, 24 and 48 hours after the intervention and reported as absolute urinary concentration (nmoles/ml) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Lipidomic, proteomic and metabolomic status measured by using omics approaches (e.g., proteomic, lipidomic, metabolomic) in the buffy coat at baseline, after 2 hours, and 7 days post-intervention. Values will be reported semi-quantitatively as fold-change. 2. Levels of DNA damage in the buffy coat measured by comet assay at baseline, after 2 hours and 7 days post intervention 3. Levels of 8-hydroxy-2'-deoxyguanosine (8-OHdG) in plasma and urine measured using ELISA kit at baseline, after 2 hours and 7 days post intervention | — |
Countries
Italy
Outcome results
None listed